AUTL
Autolus Therapeutics·NASDAQ
--
--(--)
--
--(--)
1.00 / 10
Underperform
Technical rating is 1/10 (Underperform). All four key signals—MACD death cross, long upper/lower shadows and white Marubozu—show bearish bias with win rates below 40% and negative average returns, indicating strong downside risk.
Analysis Checks(0/4)
Long Upper Shadow
Score1/10
Win Rate32.35%
Hist. Signals34
Avg Return-1.36%
Score1/10
Win Rate32.35%
Hist. Signals34
Avg Return-1.36%
MACD Death Cross
Score1/10
Win Rate33.33%
Hist. Signals6
Avg Return-1.55%
Score1/10
Win Rate33.33%
Hist. Signals6
Avg Return-1.55%
Long Lower Shadow
Score1/10
Win Rate26.67%
Hist. Signals45
Avg Return-2.02%
Score1/10
Win Rate26.67%
Hist. Signals45
Avg Return-2.02%
Marubozu White
Score1/10
Win Rate36.84%
Hist. Signals19
Avg Return-1.30%
Score1/10
Win Rate36.84%
Hist. Signals19
Avg Return-1.30%
Long Upper Shadow
Score1/10
Win Rate32.35%
Hist. Signals34
Avg Return-1.36%
Score1/10
Win Rate32.35%
Hist. Signals34
Avg Return-1.36%
Long Lower Shadow
Score1/10
Win Rate26.67%
Hist. Signals45
Avg Return-2.02%
Score1/10
Win Rate26.67%
Hist. Signals45
Avg Return-2.02%
MACD Death Cross
Score1/10
Win Rate33.33%
Hist. Signals6
Avg Return-1.55%
Score1/10
Win Rate33.33%
Hist. Signals6
Avg Return-1.55%
Marubozu White
Score1/10
Win Rate36.84%
Hist. Signals19
Avg Return-1.30%
Score1/10
Win Rate36.84%
Hist. Signals19
Avg Return-1.30%
What is the current technical signals for AUTL?
- AUTL presents a Underperform setup with a Technical Score of 1.00/10. Key technical indicators highlight an RSI of 30.89 and a MACD of -0.06, with the trend anchored by the 50-Day SMA at 1.49. Traders should monitor key support at 1.26 and resistance at 1.33.
